Skip to main content

Table 1 The prevalence of ARLD

From: Global prevalence, incidence, and outcomes of alcohol related liver diseases: a systematic review and meta-analysis

 

Studies (N)

Participations (N)

ARLD (n)

Prevalence (%, 95%CI)

I2**

P

By country area

 Overall

99

198,423,289

1,806,506

4.8% (4.1–5.6)

99.998

 < 0.001

 Portugal

1

773,187

7751

1.0% (0.9–1.1)

-

 < 0.001

 Canada

1

690,401

7112

1.0% (1.0–1.1)

-

 < 0.001

 Iceland

1

16,000

317

1.0% (0.8–1.2)

-

 < 0.001

 Denmark

3

5,531,764

11,260

1.2% (0.1–3.4)

99.990

0.046

 France

2

261,248

3663

1.4% (1.3–1.4)

-

 < 0.001

 South Korea

4

48,933,410

41,262

2.3% (0.1–7.7)

99.934

 < 0.001

 China

54

2,976,478

29,681

3.9% (2.9–5.1)

99.902

 < 0.001

 USA

17

137,929,285

1,664,682

5.0% (2.9–7.6)

100

 < 0.001

 UK

5

1,187,539

23,457

7.2% (3.0–13.0)

99.989

 < 0.001

 Japan

6

88,043

12,318

10.4% (3.2–20.9)

99.931

 < 0.001

 Uganda

1

8099

888

11.0% (7.7–10.2)

 

 < 0.001

 India

2

3229

422

11.8% (10.7–12.9)

-

 < 0.001

 Sweden

1

4611

645

14.0% (13.0–15.0)

-

 < 0.001

 Italy

3

19,995

3206

16.1% (1.2–43.3)

-

0.009

By regions

 Asia

66

52,001,160

83,683

4.5% (4.0–5.5)

99.950

 < 0.001

 North America

17

138,619,686

1,671,794

4.7% (2.7–7.1)

100

 < 0.001

 Europe

16

7,794,344

50,141

5.4% (3.9–7.1)

99.980

 < 0.001

Province of Chinaa

 Overall

54

2,976,478

29,681

3.9% (2.9–5.1)

99.903

 < 0.001

 Sichuan

5

27,775

652

1.8% (1.1–2.6)

94.661

 < 0.001

 Beijing

4

2,660,342

16,051

1.9% (0.1–5.5)

99.989

0.007

 Guangdong

5

27,835

878

1.9% (0.7–3.6)

98.563

0.001

 Jiangsu

2

8453

190

2.2% (1.9–2.5)

-

 < 0.001

 Shanghai

2

6192

192

2.9% (2.5–3.3)

-

 < 0.001

 Gansu

2

50,342

1627

3.2% (3.1–3.4)

-

 < 0.001

 Shaanxi

3

16,572

652

3.5% (1.7–6.0)

-

 < 0.001

 Guizhou

2

20,229

776

3.8% (3.6–4.1)

-

 < 0.001

 Zhejiang

7

37,375

1904

4.2% (1.8–7.5)

99.410

 < 0.001

 Henan

2

5648

241

4.2% (3.7–4.7)

-

 < 0.001

 Hunan

2

19,696

836

4.2% (3.9–4.5)

-

 < 0.001

 Jilin

4

14,462

756

4.7% (3.1–6.7)

95.180

 < 0.001

 Heilongjiang

1

1203

58

4.8% (3.7–6.2)

-

 < 0.001

 Taiwan

1

46,565

2249

4.8% (4.6–5.0)

-

 < 0.001

 Tibet

1

2178

106

4.9% (4.0–5.9)

-

 < 0.001

 Liaoning

1

7420

368

5.0% (4.5–5.5)

-

 < 0.001

 Yunnan

2

2190

159

6.8% (5.8–7.9)

-

 < 0.001

 Anhui

2

6273

581

8.0% (7.3–8.7)

-

 < 0.001

 Shandong

2

8495

692

8.1% (7.5–8.7)

-

 < 0.001

 Hebei

1

866

85

9.8% (7.9–12.0)

-

 < 0.001

 Xinjiang

1

2567

274

10.7% (9.5–11.9)

 

 < 0.001

 Northeast Chinab

5

22,851

1171

4.8% (3.7–6.0)

98.617

 < 0.001

 Northwest Chinac

8

73,281

2907

5.9% (4.2–7.9)

99.739

 < 0.001

By sex

58

195,227,050

1,265,327

 

99.993

 

 Male

  

924,436

2.9% (2.4–3.5)

 

 < 0.001

 Female

  

340,891

0.5% (0.4–0.7)

 

 < 0.001

By study period

67

122,004,134

598,920

   

 2000–2010

49

119,422,376

509,074

4.6% (4.2–5.0)

99.987

 < 0.001

 2011–2021

18

2,581,758

89,846

5.6% (2.4–10.1)

99.993

 < 0.001

  1. Because some articles provide more than one characteristics of population with ARLD, they can be used for multiple subgroup analysis. Therefore, the sum of the articles and population data is not equal to the total
  2. ARLD Alcohol related liver disease
  3. **All p values for I2 are lower than 0.05 
  4. aStudy province referred to study province, Municipality, Autonomous Region, or Special Administrative Region
  5. bNortheast China comprised data from Heilongjiang, Jilin, Liaoning
  6. cNorthwest China comprised data from Xinjiang, Shaanxi, Gansu
Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us